Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell Line

Increases in serum neopterin concentrations are a regular finding in patients with ovarian cancer. The strong correlation between neopterin and tumor progression might be explained by a direct influence of the pteridine compound on tumor cell growth. In the present study we investigated whether neop...

Full description

Bibliographic Details
Main Authors: Rieder Josef, Marth Christian, Schobersberger Wolfgang, Hoffmann Georg
Format: Article
Language:English
Published: De Gruyter 2005-11-01
Series:Pteridines
Subjects:
Online Access:https://doi.org/10.1515/pteridines.2005.16.4.166
_version_ 1818584746485088256
author Rieder Josef
Marth Christian
Schobersberger Wolfgang
Hoffmann Georg
author_facet Rieder Josef
Marth Christian
Schobersberger Wolfgang
Hoffmann Georg
author_sort Rieder Josef
collection DOAJ
description Increases in serum neopterin concentrations are a regular finding in patients with ovarian cancer. The strong correlation between neopterin and tumor progression might be explained by a direct influence of the pteridine compound on tumor cell growth. In the present study we investigated whether neopterin affects the production of the angiogenic promotors vascular endothelial growth factor (VEGF) and erythropoietin (EPO) in the human ovarian carcinoma cell line OVCAR-3. VEGF and EPO gene expression were detected via RT-PCR. and a possible involvement of hypoxiainducible factor-1 was assessed by electrophoretic mobility shift assays. Neopterin amplified the hypoxia-induced VEGF and EPO gene expression as well as protein synthesis in a concentration-dependent manner. In addition, generation of both VEGF and EPO could be detected following incubation of cells with neopterin under normoxic conditions, too. Neopterin-induced synthesis of VEGF and EPO was preceeded by a stimulation of hypoxiainducible factor-1 uptake into the nucleus of OVCAR-3 cells. From these data we conclude that neopterin acts as a mediator of angiogenesis. Stimulation of VEGF and EPO generation in ovarian carcinoma cells may promote vascularization of the malignant tissue and thus tumor growth and development.
first_indexed 2024-12-16T08:26:04Z
format Article
id doaj.art-abdfa3276a2b442c9b83a1e5b30bfdb7
institution Directory Open Access Journal
issn 0933-4807
2195-4720
language English
last_indexed 2024-12-16T08:26:04Z
publishDate 2005-11-01
publisher De Gruyter
record_format Article
series Pteridines
spelling doaj.art-abdfa3276a2b442c9b83a1e5b30bfdb72022-12-21T22:38:00ZengDe GruyterPteridines0933-48072195-47202005-11-0116416617310.1515/pteridines.2005.16.4.166Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell LineRieder Josef0Marth Christian1Schobersberger Wolfgang2Hoffmann Georg3Department of Anaesthesia and Critical Care Medicine; Innsbruck Medical University, Innsbruck, AustriaDepartment of Obstetrics and Gynaecology; Innsbruck Medical University, Innsbruck, AustriaInstitute for Leisure, Travel, and Alpine Medicine; University for Health Sciences, Medical Informatics, and Technology, Hall, AustriaInstitute for Leisure, Travel, and Alpine Medicine; University for Health Sciences, Medical Informatics, and Technology, Hall, AustriaIncreases in serum neopterin concentrations are a regular finding in patients with ovarian cancer. The strong correlation between neopterin and tumor progression might be explained by a direct influence of the pteridine compound on tumor cell growth. In the present study we investigated whether neopterin affects the production of the angiogenic promotors vascular endothelial growth factor (VEGF) and erythropoietin (EPO) in the human ovarian carcinoma cell line OVCAR-3. VEGF and EPO gene expression were detected via RT-PCR. and a possible involvement of hypoxiainducible factor-1 was assessed by electrophoretic mobility shift assays. Neopterin amplified the hypoxia-induced VEGF and EPO gene expression as well as protein synthesis in a concentration-dependent manner. In addition, generation of both VEGF and EPO could be detected following incubation of cells with neopterin under normoxic conditions, too. Neopterin-induced synthesis of VEGF and EPO was preceeded by a stimulation of hypoxiainducible factor-1 uptake into the nucleus of OVCAR-3 cells. From these data we conclude that neopterin acts as a mediator of angiogenesis. Stimulation of VEGF and EPO generation in ovarian carcinoma cells may promote vascularization of the malignant tissue and thus tumor growth and development.https://doi.org/10.1515/pteridines.2005.16.4.166neopterinvascular endothelial growth factorerythropoietinovarian carcinoma cells
spellingShingle Rieder Josef
Marth Christian
Schobersberger Wolfgang
Hoffmann Georg
Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell Line
Pteridines
neopterin
vascular endothelial growth factor
erythropoietin
ovarian carcinoma cells
title Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell Line
title_full Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell Line
title_fullStr Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell Line
title_full_unstemmed Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell Line
title_short Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell Line
title_sort neopterin as a stimulator of vascular endothelial growth factor and erythropoietin gene expression in an ovarian carcinoma cell line
topic neopterin
vascular endothelial growth factor
erythropoietin
ovarian carcinoma cells
url https://doi.org/10.1515/pteridines.2005.16.4.166
work_keys_str_mv AT riederjosef neopterinasastimulatorofvascularendothelialgrowthfactoranderythropoietingeneexpressioninanovariancarcinomacellline
AT marthchristian neopterinasastimulatorofvascularendothelialgrowthfactoranderythropoietingeneexpressioninanovariancarcinomacellline
AT schobersbergerwolfgang neopterinasastimulatorofvascularendothelialgrowthfactoranderythropoietingeneexpressioninanovariancarcinomacellline
AT hoffmanngeorg neopterinasastimulatorofvascularendothelialgrowthfactoranderythropoietingeneexpressioninanovariancarcinomacellline